Competition Law Update on Cases and Topics Relevant to the Pharma and Life Sciences Sector

This session provides a competition law update on cases and topics relevant to the pharma and life sciences sector.

In particular, we will discuss the CMA's prochlorperazine fine, the European Court's judgment in Intel regarding discount schemes companies and the impact of emerging Foreign Direct Investment reviews in the life sciences space.

We will also discuss current topics related to vertical restraints— particularly the EU Commission's consultation on its dual distribution guidance and recurring themes of distribution models involving agencies and product consignments.

Participation

Arnold & Porter's FPF group provides training seminars, events and networking opportunities aimed at in-house junior and mid-level lawyers in the life sciences industry, although all seniorities are welcome. There are no formal entry or membership requirements—please feel free to pass this invitation to colleagues who might be interested in attending.